Impact of NMES and HPRO on Recovery After SAH- Pilot Study

Exclusion Criteria

• •1. . Subjects diagnosed with SAH from trauma, rupture of an arteriovenous malformation, neoplasm, vasculitis, or other secondary causes;
• •2. . Unlikely to survive one week post hemorrhage either due to impending brain death or likely request for withdrawal of care;
• •3. . Unlikely to remain in the ICU for more than 7 days;
• •4. . Body mass index \< 15 or \>40 kg/m2;
• •5. . Allergy to whey protein;
• •6. . Evidence of lower extremity paresis or spasticity within 48 hours of injury
• •7. . Pre-morbid modified Rankin Score \>1.
• •8. . Known pregnancy
• •9. . Presence of active malignancy
• •10. . Diagnosis of an inflammatory disorder
• •11. . Presence of a neuromuscular disorder
• •12. . Diagnosis of chronic renal insufficiency or acute kidney injury (GFR \< 30 mL/min/1.73m2)
• •13. . Hepatic insufficiency defined as AST/ALT levels \>2.5 above normal upper limits.
• •14. . On-going seizure activity as assessed clinically or by electrographic detection on continuous electroencephalogram (cEEG) at time of enrollment
• •15. . Prisoner.